Washington, D.C. 20549
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o  Preliminary Proxy Statement
o  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o  Definitive Proxy Statement
þ  Definitive Additional Materials
o  Soliciting Material Pursuant to § 240.14a-12
(Name of Registrant as Specified In Its Charter)
Not applicable
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
    (1)   Title of each class of securities to which transaction applies:
    (2)   Aggregate number of securities to which transaction applies:
    (3)   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
    (4)   Proposed maximum aggregate value of transaction:
    (5)   Total fee paid:
  Fee paid previously with preliminary materials:
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
    (1)   Amount Previously Paid:
    (2)   Form, Schedule or Registration Statement No.:
    (3)   Filing Party:
    (4)   Date Filed:


*** Exercise Your Right to Vote *** IMPORTANT NOTICE Regarding the Availability of Proxy Materials
Meeting Information
Meeting Type: Annual Meeting EMERGENT BIOSOLUTIONS INC. For holders as of: March 27, 2009 Date: May 21, 2009 Time: 10:00 AM EDT            B Location: CROWNE PLAZA ROCKVILLE            A 3 RESEARCH CT            R ROCKVILLE MD 20850 C BROKER LOGO            O HERE            D You are receiving this communication because you hold            E shares in the above named company.
Return Address Line 1 Return Address Line 2 This is not a ballot. You cannot use this notice to vote Return Address Line 3 these shares. This communication presents only an 51 MERCEDES WAY EDGEWOOD NY 11717 overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy Investor Address Line 1 Investor Address Line 2 1 materials online at or easily request a Investor Address Line 3 paper copy (see reverse side). Investor Address Line 4 15 12 OF Investor Address Line 5 We encourage you to access and review all of the John Sample 2 important information contained in the proxy materials 1234 ANYWHERE STREET            before voting. ANY CITY, ON A1A 1A1 See the reverse side of this notice to obtain proxy materials and voting instructions.
Broadridge Internal Use Only
Job # Envelope # Sequence # # of # Sequence #



Before You Vote How to Access the Proxy Materials Proxy Materials Available to VIEW or RECEIVE: 1. Annual Report 2. Notice & Proxy Statement How to View Online: Have the 12-Digit Control Number available (located on the following page) and visit: How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request: 1) BY INTERNET: 2) BYTELEPHONE: 1-800-579-1639 3) BY E-MAIL*: * If requesting materials by e-mail, please send a blank e-mail with the 12-Digit Control Number (located on the following page) in the subject line. Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment            and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 07, 2009 to facilitate timely delivery. . To facilitate timely delivery please make the request as instructed above on or before
How To Vote Please Choose One of The Following Voting Methods
Vote In Person: If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at or request a paper copy of the materials, which will contain the appropriate instructions. Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.
Vote By Internet: To vote now by Internet, go to Have the 12 Digit Control Number available and follow the instructions. Internal Use Only Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.



Voting items
The Board of Directors recommends that you vote FOR the following:
1. Election of Directors Nominees 01 DANIEL J. ABDUN-NABI 02 DR. SUE BAILEY
The Board of Directors recommends you vote FOR the following proposal(s): B 2 To approve our Amended and Restated 2006 Stock Incentive Plan, which is proposed primarily for, among other            A purposes, increasing the number of shares authorized for issuance under our 2006 Stock Incentive Plan by 3,900,000 shares and extending the term of the plan from December 31, 2009 to December 31, 2019. R C 3 To ratify the selection by the audit committee of Ernst & Young LLP as our independent registered public            O accounting firm for the fiscal year ending December 31, 2009. D E NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
_3 ® 0000 0000 0000 0000020901
Broadridge Internal Use Only xxxxxxxxxx xxxxxxxxxx Cusip Job # Envelope # Sequence # # of # Sequence #



Reserved for Broadridge Internal Control Information
Voting Instructions
0000020901_4 Broadridge Internal Use Only P99999-010 Job # THIS SPACE RESERVED FOR SIGNATURES IF APPLICABLE            Envelope # 12 Sequence15 # # of # Sequence # # OF #